Showing 1 - 19 results of 19 for search 'Maxime Jullien', query time: 0.07s
Refine Results
-
1
-
2
Restoring Apoptosis with BH3 Mimetics in Mature B-Cell Malignancies by Maxime Jullien, Patricia Gomez-Bougie, David Chiron, Cyrille Touzeau
Published 2020-03-01
Article -
3
-
4
-
5
-
6
P534: FIRST-IN-HUMAN TRIAL OF TOCILIZUMAB IN COMBINATION WITH A STANDARD INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS: THE PHASE 1 TOCILAM STUDY. by Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Thierry Guillaume, Maxime Jullien, Lucie Planche, Joelle Gaschet, Patrice Chevallier
Published 2023-08-01
Article -
7
Efficacy of anti‐severe acute respiratory syndrome coronavirus 2 mRNA vaccines in adults with severe acquired aplastic anemia with or without allogeneic hematopoietic stem cell tra... by Alice Garnier, Amandine Le Bourgeois, Thierry Guillaume, Pierre Peterlin, Maxime Jullien, Marianne Coste‐Burel, Marie C Béné, Patrice Chevallier
Published 2022-11-01
Article -
8
Pre-graft vaccination or infection do not decrease COVID-19 infections in recipients of allogeneic stem cell transplantation vaccinated and/or protected by immunotherapy after tran... by Valentin Letailleur, Amandine Le Bourgeois, Thierry Guillaume, Alice Garnier, Pierre Peterlin, Maxime Jullien, Chloe Antier, Marie-Christine Béné, Patrice Chevallier
Published 2024-12-01
Article -
9
Assessment of monocytic‐myeloid‐derived suppressive cells (M‐MDSC) before and after allogeneic hematopoietic stem cell transplantation in acute leukemia patients by Pierre Peterlin, Marie C. Béné, Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, Alice Garnier, Camille Debord, Marion Eveillard, Patrice Chevallier
Published 2023-11-01
Article -
10
Strong SARS-CoV-2 T-Cell Responses after One or Two COVID-19 Vaccine Boosters in Allogeneic Hematopoietic Stem Cell Recipients by Béatrice Clémenceau, Amandine Le Bourgeois, Thierry Guillaume, Marianne Coste-Burel, Pierre Peterlin, Alice Garnier, Maxime Jullien, Jocelyn Ollier, Audrey Grain, Marie C. Béné, Patrice Chevallier
Published 2022-09-01
Article -
11
SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine by Béatrice Clémenceau, Thierry Guillaume, Marianne Coste-Burel, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Maxime Jullien, Jocelyn Ollier, Audrey Grain, Marie C. Béné, Henri Vié, Patrice Chevallier
Published 2022-03-01
Article -
12
Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation in an adult: A case report by Pierre Peterlin, Julia Bonnelye, Alice Garnier, Amandine Le Bourgeois, Thierry Guillaume, Maxime Jullien, Hervé Dutartre, Marie Le Moigne, Caroline Schmitt, Laurent Gouya, Antoine Poli, Sebastien Barbarot, Patrice Chevallier
Published 2024-04-01
Article -
13
Tocilizumab in combination with a standard induction chemotherapy in acute myeloid leukaemia patients (TOCILAM study): a single-centre, single-arm, phase 1 trialResearch in context by Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Thierry Guillaume, Yannick Le Bris, Olivier Theisen, Marie C. Béné, Marion Eveillard, Marie Rimbert, Maxime Jullien, Lucie Planche, Joelle Gaschet, Patrice Chevallier
Published 2023-10-01
Article -
14
Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response by Dhon Roméo Makanga, Maxime Jullien, Gaëlle David, Nolwenn Legrand, Catherine Willem, Léa Dubreuil, Alexandre Walencik, Cyrille Touzeau, Thomas Gastinne, Benoit Tessoulin, Steven Le Gouill, Béatrice Mahé, Katia Gagne, Patrice Chevallier, Béatrice Clemenceau, Christelle Retière
Published 2021-01-01
Article -
15
Anti‐SARS‐CoV‐2 vaccines in recipient and/or donor before allotransplant by Maxime Jullien, Marianne Coste‐Burel, Beatrice Clemenceau, Valentin Letailleur, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Berthe‐Marie Imbert, Jocelyn Ollier, Audrey Grain, Cyrille Touzeau, Philippe Moreau, Marie C Béné, Henri Vié, Patrice Chevallier
Published 2022-05-01
Article -
16
Safety and immunogenicity of a first dose of SARS‐CoV‐2 mRNA vaccine in allogeneic hematopoietic stem‐cells recipients by Patrice Chevallier, Marianne Coste‐Burel, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Marie C. Béné, Berthe‐Marie Imbert, Thomas Drumel, Steven Le Gouill, Philippe Moreau, Beatrice Mahe, Viviane Dubruille, Nicolas Blin, Anne Lok, Cyrille Touzeau, Thomas Gastinne, Maxime Jullien, Sophie Vanthygem, Thierry Guillaume
Published 2021-08-01
Article -
17
FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the... by Pierre Peterlin, Joëlle Gaschet, Pascal Turlure, Marie-Pierre Gourin, Pierre-Yves Dumas, Sylvain Thepot, Ana Berceanu, Sophie Park, Marie-Anne Hospital, Thomas Cluzeau, Jose-Miguel Torregrosa-Diaz, Louis Drevon, Rosa Sapena, Fatiha Chermat, Lionel Ades, Sophie Dimicoli-Salazar, Maxime Jullien, Pierre Fenaux, Patrice Chevallier.
Published 2024-11-01
Article -
18
Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post‐transplant cyclophosphamide by Maxime Jullien, Corentin Orvain, Ana Berceanu, Marie‐Anne Couturier, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Marion Klemencie, Aline Schmidt, Mathilde Hunault, Etienne Daguindau, Xavier Roussel, Pascal Delepine, Gaelle Guillerm, Aurelien Giltat, Sylvie François, Sylvain Thepot, Steven Le Gouill, Marie‐C Béné, Patrice Chevallier
Published 2021-10-01
Article -
19
Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation? by Baptiste Le Calvez, Maxime Jullien, Jean H. Dalle, Cécile Renard, Charlotte Jubert, Arthur Sterin, Catherine Paillard, Anne Huynh, Sarah Guenounou, Bénédicte Bruno, Virginie Gandemer, Nimrod Buchbinder, Pauline Simon, Cécile Pochon, Anne Sirvent, Dominique Plantaz, Justyna Kanold, Marie C. Béné, Fanny Rialland, Audrey Grain, Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC)
Published 2024-07-01
Article